Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance

Diabetes Care

Volumn 23, Issue 5, 2000, Pages 650-657

  Larsson, Hillevi ^a   Ahrén, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; GLUCAGON RELEASE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; PANCREAS ISLET;

EID: 0034078505     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.5.650     Document Type: Article

References (33)

1. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: 1456-1467, 1981
2. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
3. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166-1173, 1997
4. Clausen JO, Borch-Jensen K, Ibsen H, Bergman RN, Hougaard P, Winther K, Pedersen O: Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young, healthy Caucasians: analysis of the impact of gender, body fat, physical fitness, and life-style factors J Clin Invest 98: 1195-1209, 1996
5. Ward WK, Johnston CL, Beard JC, Benedetti TH, Porte D Jr: Abnormalities of islet B-cell function, insulin action, and fat distribution in women with histories of gestational diabetes: relationship to obesity. J Clin Endocrinol Metab 61:1039-1045, 1985
6. Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS, Sturis J: Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44:506-512, 1995
7. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
8. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386-1391, 1995
9. Keen H, Jarrett RJ, McCartney P: The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22:73-78, 1982
10. King H, Zimmet P, Raper LR, Balkau B: The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study. Diabetologia 26:39-43, 1984
11. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-1506, 1988
12. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39: 1201-1207, 1996
13. Larsson H, Ahrén B: Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39: 1099-1107, 1996
14. Larsson H, Ahrén B: Islet dysfunction in obese women with impaired glucose tolerance. Metabolism 45:502-509, 1996
15. Larsson H, Ahrén B, Lindgärde F, Berglund G: Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle-aged women. J Intern Med 237:537-541, 1995
16. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
17. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr: Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318-1328, 1984
18. Larsson H, Ahrén B: Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 41:772-777, 1998
19. Dimitriadis GD, Pehling GD, Gerich JE: Abnormal glucose modulation of islet α-and β-cell responses to arginine in noninsulin-dependent diabetes mellitus. Diabetes 34:541-547, 1985
20. Baron AD, Schaeffer L, Shragg P, Kolterman OG: Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes 36: 274-283, 1987
21. Assan R, Efendic S, Luft R, Cerasi E: Dosekinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell function. Diabetologia 21: 452-459, 1981
22. Hamaguchi T, Fukushima H, Uchara M, Wada S, Shirotani T, Kishikawa E, Ichinose K, Yamaguchi K, Shichiri M: Abnormal glucagon response to arginine and its normalization in obese hyperinsulinemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells. Diabetologia 34:801-806, 1991
23. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
24. Cerasi E: Potentiation of insulin release by glucose in man. Acta Endocrinol 79:511-534, 1975
25. Grill V: Time and dose dependencies for priming effect of glucose on insulin secretion. Am J Physiol 240:E24-E31, 1981
26. Halter JB, Graf RJ, Porte D Jr: Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 48:946-954, 1979
27. Porte D Jr: Banting Lecture 1990: β-Cells in type II diabetes mellitus. Diabetes 40: 166-180, 1991
28. Ahrén B, Pacini G: Impaired adaptation of first-phase insulin secretion in post-menopausal women with glucose intolerance. Am J Physiol 273:E701-E707, 1997
29. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39: 1201-1207, 1996
30. Kanatsuka A, Makino H, Sakurada M, Hashimoto N, Iwaoka H, Yamaguchi T, Taira M, Yoshida S, Yoshida A: First-phase insulin response to glucose in nenobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate. Metabolism 37:878-884, 1988
31. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
32. Maruyama H, Hisatomi A, Orci L, Grodsky GM. Unger RH: Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 74:2296-229, 1984
33. 2 identities glucagon antagonists from weak partial agonists/antagonists. Endocrinology 137:3316-3322, 1996